Peter Hu has more than 10 years’ experience in medicine discovery and transformation research, as well as early development experience in academic and pharmaceutical industry. He studied and worked in US medical schools, hospitals and medical centers for 17 years. He received Ph. D. in medical sciences at MUO and postdoctoral training from Yale Medical School. In 2009, he returned to China and act as the R & D director of Ellis medicine and Yangtze River Pharmaceutical Group Co., Ltd respectively. He led multi-disciplinary teams and R & D projects. In addition, he led the development of innovative drugs, including 1 NDA, 3 IND and 2 PCC. Dr. Hu Yi has 27 national or international invention patent authorizations or applications and has won scientific talent award of Shanghai Zhangjiang in 2017.